Share

July 03, 2012; 79 (1) NeuroImages

Cranial nerve involvement in infratentorial progressive multifocal leukoencephalopathy

Jérôme Hodel, Olivier Outteryck, Hélène Zéphir, Mathieu Rodallec, Marc Zins, Patrick Vermersch, Xavier Leclerc
First published July 2, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31825dce72
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
917

Share

Article Information

vol. 79 no. 1 104-105
DOI: 
https://doi.org/10.1212/WNL.0b013e31825dce72
PubMed: 
22753446
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published July 2, 2012.
Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Jérôme Hodel, MD
  1. Jérôme Hodel, MD
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

    1. Olivier Outteryck, MD and
    2. Hélène Zéphir, MD
  2. Olivier Outteryck, MD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Bayer Schering Pharma, funding for travel and speaker honoraria; Biogen Idec, funding for travel and speaker honoraria; Merck Serono, funding for travel; Novartis, funding for travel; Sanofi-Aventis, funding for travel and speaker honoraria; Teva Pharmaceutical Industries Ltd, funding for travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Hélène Zéphir, MD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

    1. Mathieu Rodallec, MD and
    2. Marc Zins, MD
  4. Mathieu Rodallec, MD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Marc Zins, MD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

    1. Patrick Vermersch, MD, PhD and
    2. Xavier Leclerc, MD, PhD
  6. Patrick Vermersch, MD, PhD and
    7. Scientific Advisory Boards:

    1. Serves on scientific advisory boards for; Sanofi; Biogen Idec; Merck Serono; Teva; Novartis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Biogen Idec, travel and speaker honoraria; Bayer Schering Pharma, travel and speaker honoraria; Novartis, honoraria; Teva, travel and honoraria; Sanofi-Aventis, honoraria; Merck Serono, travel and honoraria

    Editorial Boards:

    1. journal editor for Neurones, Neurosciences et sclérose en plaques

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultancies for; Merck Serono; Sanofi; Teva; Biogen Idec; Bayer Schering Pharma

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Research support from; Biogen Idec; Bayer Schering Pharma; Novartis; Merck Serono; Teva; Sanofi

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Xavier Leclerc, MD, PhD
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editor in chief of the Journal of Neuroradiology between 2007 and 2011.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Lille and Paris
  1. Lille
  1. Paris
  1. Lille, France
  1. Correspondence & reprint requests to Dr. Hodel: jerome.hodel{at}hmn.aphp.fr
View Full Text

Article usage

Article usage: June 2012 to April 2023

AbstractFullPdfSource
Jun 2012711Highwire
Jul 2012888239154Highwire
Aug 2012702224Highwire
Sep 2012392516Highwire
Oct 2012351623Highwire
Nov 201230610Highwire
Dec 20121947Highwire
Jan 2013342410Highwire
Feb 2013132910Highwire
Mar 201315388Highwire
Apr 201315264Highwire
May 201318196Highwire
Jun 20131187Highwire
Jul 2013924Highwire
Aug 2013974Highwire
Sep 2013821Highwire
Oct 20131256Highwire
Nov 2013766Highwire
Dec 2013523Highwire
Jan 2014586Highwire
Feb 2014633Highwire
Mar 2014553Highwire
Apr 2014623Highwire
May 2014538Highwire
Jun 2014012Highwire
Jul 20141424Highwire
Aug 2014526Highwire
Sep 2014334Highwire
Oct 20148610Highwire
Nov 2014514Highwire
Dec 20141427Highwire
Jan 2015027Highwire
Feb 2015224Highwire
Mar 2015914Highwire
Apr 2015725Highwire
May 20151135Highwire
Jun 2015555Highwire
Jul 20151869Highwire
Aug 20151029Highwire
Sep 20151184Highwire
Oct 2015868Highwire
Nov 2015802Highwire
Dec 20151344Highwire
Jan 2016873Highwire
Feb 2016511Highwire
Mar 201631015Highwire
Apr 2016632Highwire
May 2016323Highwire
Jun 20161184Highwire
Jul 20167312Highwire
Aug 2016934Highwire
Sep 2016315Highwire
Oct 20169110Highwire
Nov 2016724Highwire
Dec 2016514Highwire
Jan 2017631Highwire
Feb 2017278Highwire
Mar 2017428Highwire
Apr 2017633Highwire
May 20171507Highwire
Jun 2017103Highwire
Jul 2017213Highwire
Aug 2017506Highwire
Sep 2017324Highwire
Oct 2017315Highwire
Nov 2017432Highwire
Dec 2017011Highwire
Jan 20180133Highwire
Feb 2018013Highwire
Mar 2018151Highwire
Apr 2018023Highwire
May 2018096Highwire
Jun 2018072Highwire
Jul 20180126Highwire
Aug 20180611Highwire
Sep 2018034Highwire
Oct 2018074Highwire
Nov 2018098Highwire
Dec 2018075Highwire
Jan 20190133Highwire
Feb 2019084Highwire
Mar 2019065Highwire
Apr 2019026Highwire
May 2019353Highwire
Jun 2019135Highwire
Jul 2019168Highwire
Aug 2019042Highwire
Sep 2019053Highwire
Oct 2019278Highwire
Nov 2019183Highwire
Dec 20190108Highwire
Jan 20200117Highwire
Feb 2020061Highwire
Mar 2020042Highwire
Apr 2020094Highwire
May 2020043Highwire
Jun 2020375Highwire
Jul 2020062Highwire
Aug 2020095Highwire
Sep 20201144Highwire
Oct 20200311Highwire
Nov 20201811Highwire
Dec 2020265Highwire
Jan 2021135Highwire
Feb 2021118Highwire
Mar 2021016Highwire
Apr 20211515Highwire
May 2021144Highwire
Jun 2021022Highwire
Jul 2021258Highwire
Aug 2021124Highwire
Sep 20210111Highwire
Oct 20211726Highwire
Nov 20212715Highwire
Dec 2021085Highwire
Jan 20221611Highwire
Feb 20221144Highwire
Mar 2022054Highwire
Apr 20220114Highwire
May 2022265Highwire
Jun 2022236Highwire
Jul 2022062Highwire
Aug 2022052Highwire
Sep 2022029Highwire
Oct 2022075Highwire
Nov 20220812Highwire
Dec 2022062Highwire
Jan 2023125Highwire
Feb 2023296Highwire
Mar 2023184Highwire
Apr 2023045Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles